omeprazole has been researched along with Deficiency, Magnesium in 19 studies
Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Etiologic investigations led to the discovery of Giardiasis lamblia on duodenal biopsies and a long-term treatment with proton pump inhibitors (PPI) (omeprazole followed by esomeprazole), both being recently described as causal factors of hypomagnesemic hypoparathyroidism." | 3.74 | [Chronic use of proton-pump inhibitors associated with giardiasis: A rare cause of hypomagnesemic hypoparathyroidism?]. ( Caron, J; Durlach, V; François, M; Lévy-Bohbot, N, 2008) |
| "Two cases of severe hypomagnesaemia in adult long-term users of the PPI omeprazole, presenting with hypocalcaemic seizures." | 3.74 | Severe hypomagnesaemia in long-term users of proton-pump inhibitors. ( Cundy, T; Dissanayake, A, 2008) |
| "The enteral bioavailability of magnesium firmly bound to a fire-proof, inert SiO2-Al2O3 matrix (ground magnesia boats) was studied in magnesium-deficient albino Sprague-Dawley rats, with and without blocking gastric hydrochloric acid secretion with omeprazole." | 1.29 | Erythema formation in magnesium-deficient albino rats. A non-invasive model for the screening of anti-inflammatory agents and oral mineral supplements. ( Abele, C; Classen, CU; Classen, HG; Friedberg, KD; Haubold, W; Schimatschek, HF, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (5.26) | 18.2507 |
| 2000's | 4 (21.05) | 29.6817 |
| 2010's | 13 (68.42) | 24.3611 |
| 2020's | 1 (5.26) | 2.80 |
| Authors | Studies |
|---|---|
| Isse, N | 1 |
| Hashimoto, M | 1 |
| Koh, ZY | 1 |
| Lim, SWM | 1 |
| Lim, WS | 1 |
| Semb, S | 1 |
| Helgstrand, F | 1 |
| Hjørne, F | 1 |
| Bytzer, P | 1 |
| van den Berg, S | 1 |
| Scheer, MLJ | 1 |
| Holman, ND | 1 |
| Thongon, N | 1 |
| Penguy, J | 1 |
| Kulwong, S | 1 |
| Khongmueang, K | 1 |
| Thongma, M | 1 |
| Eberhard, J | 1 |
| Macdonald, A | 1 |
| Cundy, T | 2 |
| François, M | 1 |
| Lévy-Bohbot, N | 1 |
| Caron, J | 1 |
| Durlach, V | 1 |
| Shabajee, N | 1 |
| Lamb, EJ | 1 |
| Sturgess, I | 1 |
| Sumathipala, RW | 1 |
| Doornebal, J | 1 |
| Bijlsma, R | 1 |
| Brouwer, RM | 1 |
| Gato Diez, A | 1 |
| Córdoba Soriano, JG | 1 |
| Mora Escudero, I | 1 |
| Fernández-Fernández, FJ | 2 |
| Sesma, P | 2 |
| Caínzos-Romero, T | 2 |
| Ferreira, L | 1 |
| Ferreira-González, L | 1 |
| Callejas Díaz, A | 1 |
| Montero Hernández, E | 1 |
| Gil Navarro, M | 1 |
| Tutor-Ureta, P | 1 |
| Yebra Bango, M | 1 |
| Vargas Núñez, JA | 1 |
| Gutiérrez Macías, A | 1 |
| Ibarmia Lahuerta, J | 1 |
| Alvarez De Castro, M | 1 |
| Lizarralde Palacios, E | 1 |
| Swaminathan, K | 1 |
| Wilson, J | 1 |
| Famularo, G | 1 |
| Minisola, G | 1 |
| Bravi, MC | 1 |
| Colucci, P | 1 |
| Gasbarrone, L | 1 |
| Bai, JP | 1 |
| Hausman, E | 1 |
| Lionberger, R | 1 |
| Zhang, X | 1 |
| Dissanayake, A | 1 |
| Classen, CU | 1 |
| Abele, C | 1 |
| Schimatschek, HF | 1 |
| Friedberg, KD | 1 |
| Classen, HG | 1 |
| Haubold, W | 1 |
19 other studies available for omeprazole and Deficiency, Magnesium
| Article | Year |
|---|---|
Omeprazole-induced hypomagnesaemia, causing renal tubular acidosis with hypokalaemia, hypocalcaemia, hyperlactacidaemia and hyperammonaemia.
Topics: Acidosis, Renal Tubular; Aged; Humans; Hyperammonemia; Hyperlactatemia; Hypocalcemia; Hypokalemia; M | 2020 |
An Interesting Case of "Refractory" Hypomagnesemia.
Topics: Aged, 80 and over; Gastric Mucosa; Gastroesophageal Reflux; Humans; Magnesium Deficiency; Male; Omep | 2017 |
Persistent severe hypomagnesemia caused by proton pump inhibitor resolved after laparoscopic fundoplication.
Topics: Administration, Oral; Aged; Fundoplication; Gastroesophageal Reflux; Humans; Infusions, Intravenous; | 2017 |
[Severe hypomagnesaemia due to proton pump inhibitor use].
Topics: Aged; Female; Humans; Magnesium Deficiency; Omeprazole; Proton Pump Inhibitors | 2018 |
Omeprazole suppressed plasma magnesium level and duodenal magnesium absorption in male Sprague-Dawley rats.
Topics: Animals; Anti-Ulcer Agents; Cation Transport Proteins; Claudins; Duodenum; Intestinal Absorption; Ma | 2016 |
Severe proton pump inhibitor-induced hypomagnesaemia in a mother and daughter.
Topics: Aged, 80 and over; Female; Humans; Magnesium Deficiency; Middle Aged; Mothers; Nuclear Family; Omepr | 2017 |
[Chronic use of proton-pump inhibitors associated with giardiasis: A rare cause of hypomagnesemic hypoparathyroidism?].
Topics: Deglutition Disorders; Duodenum; Esomeprazole; Female; Giardiasis; Humans; Hypocalcemia; Hypoparathy | 2008 |
Omeprazole and refractory hypomagnesaemia.
Topics: Aged; Aged, 80 and over; Anti-Ulcer Agents; Chronic Disease; Female; Humans; Hypocalcemia; Hypokalem | 2008 |
[An unknown but potentially serious side effect of proton pump inhibitors: hypomagnesaemia].
Topics: Aged; Aged, 80 and over; Anti-Ulcer Agents; Female; Humans; Hypocalcemia; Hypokalemia; Hypoparathyro | 2009 |
[Severe hypomagnesaemia due to long-term treatment with omeprazole].
Topics: Aged; Enzyme Inhibitors; Humans; Magnesium Deficiency; Male; Omeprazole; Severity of Illness Index | 2011 |
[Hypomagnesemia related to the use of omeprazole with negative result for mutation in the TRPM6 gene].
Topics: Aged; Alcoholism; Esophagitis, Peptic; Famotidine; Histamine H2 Antagonists; Humans; Intestinal Abso | 2011 |
Intermittent use of pantoprazole and famotidine in severe hypomagnesaemia due to omeprazole.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Famotidine; Histamine H2 Antagonis | 2010 |
[Omeprazole and hypomagnesemia].
Topics: Enzyme Inhibitors; Humans; Magnesium Deficiency; Male; Middle Aged; Omeprazole | 2011 |
[Severe hypomagnesemia related to omeprazole].
Topics: Aged, 80 and over; Anti-Ulcer Agents; Humans; Magnesium Deficiency; Male; Middle Aged; Omeprazole | 2011 |
Elusive cause of hypomagnesaemia.
Topics: Anti-Ulcer Agents; Humans; Hydroxycholecalciferols; Infusions, Intravenous; Magnesium Compounds; Mag | 2011 |
Tetany, hypomagnesemia, and proton-pump inhibitors.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Biomarkers; Female; Humans; Hypoparathyroidism; Magnesium; | 2012 |
Modeling and simulation of the effect of proton pump inhibitors on magnesium homeostasis. 1. Oral absorption of magnesium.
Topics: Administration, Oral; Computer Simulation; Homeostasis; Humans; Intestinal Absorption; Magnesium; Ma | 2012 |
Severe hypomagnesaemia in long-term users of proton-pump inhibitors.
Topics: Aged; Female; Gastroesophageal Reflux; Humans; Hypocalcemia; Magnesium Deficiency; Male; Middle Aged | 2008 |
Erythema formation in magnesium-deficient albino rats. A non-invasive model for the screening of anti-inflammatory agents and oral mineral supplements.
Topics: Animals; Anti-Inflammatory Agents; Biological Availability; Cromolyn Sodium; Diet; Disease Models, A | 1993 |